Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

HER2 Negative Breast Cancer × Goserelin × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 84 Breast Neoplasms, Male 6 Advanced Breast Cancer 3 Neoplasms 2 Neoplasm Metastasis 2 Infertility 2 Triple Negative Breast Neoplasms 1 Primary Ovarian Insufficiency 1 Patient Compliance 1 Osteitis Deformans 1 Inflammatory Breast Neoplasms 1 Hyperlipidemias 1 Hormone-sensitive Metastatic Breast Cancer 1 Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer 1 Hereditary Sensory and Autonomic Neuropathies 1 HER2-positive Breast Cancer 1 HER2 Negative Breast Cancer 1 Breast Diseases 1 Breast Cancer Invasive 1 Anatomic Stage I Breast Cancer AJCC v8 1 Advanced Metastatic Breast Cancer 1

Interventions

ribociclib 1 Tretinoin 1 Letrozole 1 Goserelin 1 Drug Therapy 1 Chemotherapy, Adjuvant 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06953882 2025-07-14

SELECT

Yale University

Phase 2 Recruiting

HER2 Negative Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡